Vidyya has news that the FDA has approved the first NDA for the thyroid hormone replacement drug, levothyroxine sodium (Unithroid) for use in adults and children. Although oral levothyroxine drugs products have been marketed in the United States since the 19950s, the approval of Unithroid represents the first time that a single ingredient oral levothryoxine product has been approved by the FDA.
The National Heart, Blood and Lung Institute wants to find out if community volunteers can learn to effectively use automatic external defibrillators as well as trained emergency medical personnel. To get the answer, the institute has set up a large, clinical trial. The 2 ½ year study will be conducted in 24 centers throughout the US and Canada. Volunteers in participating communities will be trained to recognize cardiac arrest, to access the 911 system, and to perform cardiopulmonary resuscitation.
In the month of August, the NIH held a consensus development conference on the use of antenatal corticosteroids. The NIH organized this conference to present research on repeat courses of antenatal corticosteroid therapy. Since preterm delivery is a major cause of death and illness in infants, corticosteroid treatment of pregnant women who deliver prematurely was introduced to enhance fetal lung maturity. Subsequent research focused on the ability of corticosteroids to reduce mortality and brain injury in preterm neonates. How many courses of steroids should be given had remained in question until now. Vidyya has both the summary and draft statment available for you.
Finally, it's back to school and back to exposure to allergens and infections. A new survey by the American Academy of
Allergy, Asthma and Immunology (AAAAI) of allergists, immunologists and school
nurses showed that children with asthma and allergies often have reactions to
triggers in the classroom. We offer some tips that parents can follow to help reduce the frequency and the severity of these reactions.
Articles in today's Vidyya are:
As always, we hope you enjoy the issue.